Graeber, Michael

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., & Evaluator Group, T. E. (2001) · Experimental Dermatology

Dermatology and Skin DiseasesReliability and Agreement in Measurement

Cited by 1,200

Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: Results of a multicenter, randomized double-blind, controlled study

Thiboutot, D. M., Weiss, J., Bucko, A., Eichenfield, L., Jones, T., Clark, S., Liu, Y., Graeber, M., & Kang, S. (2007) · Journal of the American Academy of Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 183

Adapalene-benzoyl peroxide, a unique fixed-dose combination topical gel for the treatment of acne vulgaris: a transatlantic, randomized, double-blind, controlled study in 1670 patients

Gollnick, H. P. M., Draelos, Z., Glenn, M. J., Rosoph, L. A., Kaszuba, A., Cornelison, R., Gore, B., Liu, Y., Graeber, M., & for the Adapalene-BPO Study Group (2009) · British Journal of Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 128

Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial

Thiboutot, D., Pariser, D. M., Egan, N., Flores, J., Herndon, J. H., Kanof, N. B., Kempers, S. E., Maddin, S., Poulin, Y. P., Wilson, D. C., et al. (2006) · Journal of the American Academy of Dermatology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 67

Clinical Pharmacology and Safety of Trifarotene, a First‐in‐Class RARγ‐Selective Topical Retinoid

Wagner, N., Benkali, K., Alió Sáenz, A., Poncet, M., & Graeber, M. (2020) · The Journal of Clinical Pharmacology

Acne and Rosacea Treatments and EffectsDermatology and Skin Diseases

Cited by 33